Syndax Pharmaceuticals, Inc. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
Syndax Pharmaceuticals, Inc. (SNDX) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $11.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2019-03-07
- 2018-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $11.00K.
- 2017-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $3.00K.
- 2016-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $6.00B.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2018-12-31 | $11.00K 10-K · filed 2019-03-07 |
| 2017-12-31 | $3.00K 10-K · filed 2018-03-08 |
| 2016-12-31 | $6.00B 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |